Abstract:Objective The goal was to investigate the role and intracellular regulatory mechanisms of double‐negative T (DNT) cells in the pathogenesis of systemic lupus erythematosus (SLE). Methods DNT cells were assessed in murine models, patients with SLE, and controls using flow cytometry (FCM). DNT cells from either resiquimod (R848) or vehicle‐treated C57BL/6 (B6) mice were cultured with B cells from R848‐treated mice to explore functions. Differential mechanistic target of rapamycin (mTOR) pathway signaling in DNT cells measured using FCM and quantitative polymerase chain reaction was validated by rapamycin inhibition. Candidate lipid metabolites detected using liquid chromatography with electrospray ionization mass spectrometry/mass spectrometry were functionally assessed in DNT cell cultures. Results DNT cells were markedly increased in both spontaneous and induced mouse lupus models and in patients with SLE. Expanded DNT cells from R848‐treated B6 mice produced elevated interleukin (IL)‐17A and IgG with increased germinal center B (GCB) cells. Expansion of DNT cells associated with activation of mTORC1 pathway that both IL‐17A levels and the number of DNT cells exhibited dose‐dependent reduction with rapamycin treatment. Lipidomics studies revealed differential patterns of lipid metabolites in T cells of R848‐treated mice. Among candidate metabolites, elevated phosphatidic acid (PA) that was partially controlled by phospholipase D2 increased the expression of the mTORC1 downstream target p‐S6 and positively expanded IL‐17A–producing DNT cells. Similarly, elevated proportions of circulating DNT cells in patients with SLE correlated with disease activity and proteinuria, and IL‐17A secretion was elevated after in vitro PA stimulation. Conclusion The accumulation of PA in T cells could activate the mTORC1 pathway, promoting DNT cell expansion and IL‐17A secretion, resulting in GCB cell abnormalities in lupus. image

The PP2A regulatory subunit PPP2R2A controls NAD+ biosynthesis to regulate T cell subset differentiation in systemic autoimmunity

Neuropilin-1 Identifies a New Subpopulation of TGF--Induced Foxp3<SUP>+</SUP> Regulatory T Cells With Potent Suppressive Function and Enhanced Stability During Inflammation

Phosphatase PP2A is Essential for T H 17 Differentiation

Phosphatase PP2A is essential for TH17 differentiation.

Methyltransferase Setd2 Prevents T Cell-Mediated Autoimmune Diseases Via Phospholipid Remodeling

Essential Role of NPAT in Regulating T Cell Development and Function

Programmed Death 1 Ligand (Pd-L) 1 And Pd-L2 Limit Autoimmune Kidney Disease: Distinct Roles

NLRP3 and ASC suppress lupus-like autoimmunity by driving the immunosuppressive effects of TGF-β receptor signalling

Redox regulation of PTPN22 affects the severity of T-cell-dependent autoimmune inflammation

Protein phosphatase 2A propels follicular T helper cell development in lupus

NADPH oxidase in B cells and macrophages protects against murine lupus by regulation of TLR7

Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation

Negative Regulation of NIP45 Function by Peptidylarginine Deminase 4 (87.28)

Protein phosphatase 6 (Pp6) is crucial for regulatory T cell function and stability in autoimmunity

Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics

Notch1 hyperactivity drives ubiquitination of NOX2 and dysfunction of CD8+ regulatory T cells in patients with systemic lupus erythematosus

Block of Both TGF-β and IL-2 Signaling Impedes Neurophilin-1+ Regulatory T Cell and Follicular Regulatory T Cell Development.

Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice

The NCF1 variant p.R90H aggravates autoimmunity by facilitating the activation of plasmacytoid dendritic cells

Loss of RPA1 Impairs Peripheral T Cell Homeostasis and Exacerbates Inflammatory Damage Through Triggering T Cell Necroptosis

Phosphatidic Acid Promoting the Generation of Interleukin-17A Producing Double-Negative T Cells by Enhancing Mtorc1 Signaling in Lupus